Skip to main content

Main navigation

  • Expertise
  • Publications & Insights
  • People
  • Careers

Secondary navigation

  • Value added services
  • CSR
  • About us

SearchSearch results for: “”

509 results

Rein Wesseling

Partner Amsterdam

Lucie Thébault

Professional Support Lawyer Brussels

Roos Elemans

Partner Amsterdam

Hans Van Bavel

Partner Brussels

Sophie Van Besien

Partner Brussels

Shila Kobakiwal

Associate Amsterdam

Simone Evans

Senior Professional Support Lawyer (not admitted to the bar) Amsterdam

Stijn de Jong

Partner Amsterdam

Tim de Greve

Partner Amsterdam

Tjaša Geč-Senčur

Senior Associate Amsterdam

David Verwaerde

Counsel Brussels

Peter Wytinck

Partner Brussels

Mondelēz’s fine takes the biscuit: cross-border trade crusade peaks

The European Commission has fined Mondelēz EUR 337.5 million for restricting cross-border trade. Brand owners are advised to double-check their licensing and distribution systems, as well as their commercial conduct, for possible territorial restraints.

Happy first anniversary! One year of the Vifo Act: an update

On the first of June, the Dutch national security investment screening regime (the Vifo Act) celebrated its first anniversary. Time to take stock of key findings and forthcoming developments.

Commission takes labour market enforcement to the next level

Employers beware: the European Commission is strengthening its actions against anticompetitive practices in labour markets. In its recent Competition Policy Brief it takes a tough stance. Companies are well-advised to review their employment practices.

Game over for dark patterns? ACM fines Epic for unfairly targeting children

The ACM has fined Epic Games for exploiting children’s psychological vulnerabilities, marking a key moment for Dutch consumer law enforcement. Our briefing examines the broader implications for consumer-facing businesses, especially those in online sales.

Stibbe advises Viatris in sale of substantially all of Viatris’ European OTC Business to Cooper Consumer Health

Stibbe successfully guides Viatris through EU regulatory processes.

Killing three birds with one stone: Illumina wins Article 22 battle

The ECJ wrote the epilogue to the Illumina/Grail saga, overturning the EC’s novel ‘Article 22’ approach. It is now clear that the EC cannot accept referral requests to review transactions that fall below the thresholds of national merger control regimes.

Pagination

  • Previous page
  • Page 8
  • Current page 9
  • Page 10
  • Page 11
  • Next page
Reset filters
Date
Content type
  • Article (342)
  • Event (7)
  • Inside Stibbe (10)
  • Matter (107)
  • Podcast (3)
  • People (40)
Expertise
  • (-) Corporate Investigations (31)
  • (-) EU and Competition Law (488)
  • Audit Firms and Accountancy (76)
  • Banking and Finance (422)
  • Capital Markets (243)
  • Compliance, Sanctions and Risk (163)
  • Corporate and M&A (856)
  • Criminal Law and Enforcement (141)
  • Digital Economy (106)
  • Employment, Benefits and Pensions (407)
  • Energy, Industry and Climate (310)
  • Environment and Planning (870)
  • ESG & Sustainability (289)
  • Financial Regulation (167)
  • Healthcare and Life Sciences (85)
  • Infrastructure and Mobility (193)
  • Insurance (36)
  • Intellectual Property (117)
  • Investment Funds (136)
  • Litigation and Arbitration (421)
  • Privacy and Data Protection (202)
  • Private Equity (196)
  • Procurement Law (122)
  • Public Law (1170)
  • Real Estate (466)
  • Restructuring and Insolvency (115)
  • Sports (25)
  • Stibbe StartsUP (29)
  • Tax (438)
  • Technology, Media and Telecommunications (327)
  • Unfair Competition and Consumer Protection (186)
Jurisdiction
  • BE Law (69)
  • EU Law (288)
  • LU Law (15)
  • NL Law (326)
Language
  • Dutch (44)
  • English (461)
  • French (4)

Footer main navigation

  • Expertise
  • Publications & Insights
  • People
  • Careers
© 2025 Stibbe

Footer navigation

  • Contact
  • Disclaimer
  • General Conditions
  • Register of legal practice areas
  • Privacy and Cookie Policy
  • Cookies Settings
  • Important Information